MiniMed Group Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023
Revenue	3,102	2,715	2,469	2,245
Revenue Growth	14.25%	9.96%	9.98%	-
Cost of Revenue	1,422	1,187	1,032	937
Gross Profit	1,680	1,528	1,436	1,308
Selling, General & Admin	1,183	1,080	1,057	960
Research & Development	448	436	437	429
Other Operating Expenses	239	157	11	-12
Total Operating Expenses	1,870	1,673	1,505	1,377
Operating Income	-190	-146	-69	-69
Total Non-Operating Income (Expense)	1	-1	-1	-7
Pretax Income	-189	-147	-70	-76
Provision for Income Taxes	128	52	38	16
Net Income	-317	-198	-107	-92
Minority Interest in Earnings	16	15	5	5
Net Income to Common	-333	-213	-112	-96
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	257	253	253	-
Shares Outstanding (Diluted)	257	253	253	-
Shares Change	1.50%	-	-	-
EPS (Basic)	-1.30	-0.84	-0.44	-
EPS (Diluted)	-1.30	-0.84	-0.44	-
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 24, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023
Free Cash Flow	-420	-53	-107	-173
Free Cash Flow Growth	-	-	-	-
Free Cash Flow Per Share	-1.64	-0.21	-0.42	-
Gross Margin	54.16%	56.28%	58.16%	58.26%
Operating Margin	-6.13%	-5.38%	-2.79%	-3.07%
Profit Margin	-10.22%	-7.29%	-4.33%	-4.10%
FCF Margin	-13.54%	-1.95%	-4.33%	-7.71%
EBITDA	-34	-3	60	46
EBITDA Margin	-1.10%	-0.11%	2.43%	2.05%
EBIT	-190	-146	-69	-69
EBIT Margin	-6.13%	-5.38%	-2.79%	-3.07%
Effective Tax Rate	-67.72%	-35.37%	-54.29%	-21.05%

SEC Filings: 10-K · 10-Q